Therapeutic Promise of Hyaluronidase in Systemic Sclerosis: A Systematic Review
Introduction: Systemic sclerosis, also known as scleroderma, is a chronic disease marked by autoimmune-mediated damage to connective tissues leading to vascular damage, tissue injury, and fibrosis. Effective treatment for this condition has remained difficult; however, a promising therapeutic option...
Saved in:
Main Authors: | Anika Pulumati (Author), Rachel Lin (Author), Scott Elman (Author) |
---|---|
Format: | Book |
Published: |
Mattioli1885,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A novel hyaluronidase from brown spider (Loxosceles intermedia) venom (Dietrich's Hyaluronidase): from cloning to functional characterization.
by: Valéria Pereira Ferrer, et al.
Published: (2013) -
Hyaluronidase for Dermal Filler Complications: Review of Applications and Dosage Recommendations
by: George Kroumpouzos, et al.
Published: (2024) -
Pretibial myxedema treated with intralesional hyaluronidase and triamcinolone
by: Natalie Kudlak, DO, et al.
Published: (2020) -
Isolation and Identification of Hyaluronidase Producing Staphylococcus aureus
by: Furqan M. K, et al.
Published: (2016) -
Extension-elicited blanching of the dorsal phalanges in systemic sclerosis: A case series
by: Elisa M. Schunkert, MD, et al.
Published: (2022)